Clinical trial / 1985
In hyperlipidemic subjects, unmodified niacin showed greater lipid and lipoprotein improvements than time-release niacin, along with higher adherence at 3.0 g/d.
Seventy-one primarily hypercholesterolemic subjects were randomized to unmodified niacin or time-release niacin for six months. At 3.0 g/d, adherence exceeded 90% for unmodified niacin but was 64% for time-release niacin, primarily due to aggravated gastrointestinal symptoms, though flushing was slightly less common with time-release niacin. Unmodified niacin reduced LDL cholesterol by 21% and plasma total triglyceride by 27%, compared to reductions of 13% and 8% maximum with time-release niacin. HDL-C and HDL2-C increased significantly with unmodified niacin (26% and 36%) but were not significantly changed by time-release niacin; HDL3-C increased approximately 35% and apoA-I increased approximately 12% on both regimens.
- Study type
- Randomized trial
- Who was studied
- 71 primarily hypercholesterolemic subjects
- What was measured
- Lipoprotein lipids (including HDL2 and HDL3), apoproteins A-I and A-II, clinical chemistries, side effects, and adherence
THE PAPER
Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin.
Knopp RH, Ginsberg J, Albers JJ, Hoff C, Ogilvie JT, Warnick GR, Burrows E, Retzlaff B, Poole M. Metabolism, 1985.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.